TIFFANY WILLENBERG: Open Payments
NPI 1093573032 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$59 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $37 · 2025 $59
Food & beverage: $59
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| ACADIA Pharmaceuticals Inc | 1 | $17 |
Products named: INGREZZA, ZEPBOUND, NUPLAZID.
Industry payments across AR — which companies pay providers there.
